The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - ARIAD (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Research Funding - ARIAD (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Elevated blood pressure (BP) and adverse events (AEs) of hypertension (HTN) in ponatinib (PON) leukemia trials.
 
Hanna Jean Khoury
Honoraria - ARIAD
Research Funding - ARIAD
 
Michele Baccarani
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Novartis; Pfizer
Speakers' Bureau - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Travel, Accommodations, Expenses - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
 
Francois Guilhot
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Novartis
 
Andreas Hochhaus
Research Funding - ARIAD
 
Timothy P. Hughes
No Relationships to Disclose
 
Jeffrey Howard Lipton
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Travel, Accommodations, Expenses - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
 
Stephanie Lustgarten
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Kumiko Yanase
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Maureen G Conlan
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Jorge E. Cortes
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; Teva
 
Michael W.N. Deininger
Honoraria - ARIAD; Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Novartis (Inst)
Expert Testimony - Bristol-Myers Squibb
Travel, Accommodations, Expenses - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
 
Hagop M. Kantarjian
Research Funding - Amgen (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Delta-Fly Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Neil P. Shah
Research Funding - ARIAD; Bristol-Myers Squibb; Daiichi Sankyo; Pfizer; Plexxikon
 
Moshe Talpaz
Consulting or Advisory Role - ARIAD; Novartis; Pfizer
Research Funding - ARIAD; Incyte; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - ARIAD; Incyte; Novartis; Pfizer
 
Michael J. Mauro
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Novartis